Gypsy Bay Genomics is a DOD spinout commercializing the Molecular Pap, a diagnostic that detects cervical cancer caused by the sexually transmitted virus HPV. Our technology is designed to be accurate, automatable, low cost, and complementary to self-sampling methods applicable to any anatomical site. Our ultimate goal is to offer an FDA approved test that is simple, personal, affordable, and easily available for the improvement of global health.